【摘 要】
:
Purpose: To track mesenchymal stem cells (MSCs) labeled with internalizing quantum dots (i-QDs) in the reparative tissues following the allogeneic transplantation of three dimensional (3D) cartilagino
【机 构】
:
Department of Orthopaedics Surgery Ibaraki Southwest Medical Center Japan
论文部分内容阅读
Purpose: To track mesenchymal stem cells (MSCs) labeled with internalizing quantum dots (i-QDs) in the reparative tissues following the allogeneic transplantation of three dimensional (3D) cartilaginous aggregates into the osteochondral defects of rabbits.Methods: QDs were conjugated with a unique internalizing antibody against a heat-shock-protein-70 (hsp70)-family stress chaperon, mortalin, that is up-regulated and expressed on the surface of dividing cells.The i-QDs were added to the culture medium for 24 hours.Scaffold-free cartilaginous aggregates formed from i-QDs labeled MSCs (i-MSCs) using a 3D culture system with chondrogenic supplements for one week were transplanted into osteochondral defects of rabbits.At 4, 8 and 26 weeks after the transplantation, the reparative tissues were evaluated macroscopically,histologically and fluoroscopically.Results: At as early as 4 weeks, the defects were covered with a white tissue resembling articular cartilage.In histological appearance, the reparative tissues resembled hyaline cartilage on safranin-O staining throughout the 26 weeks.In the deeper portion, subchondral bone and bone marrow were well remodeled.On fluoroscopic evaluation, QDs were tracked mainly in bone marrow stromata with some signals detected in cartilage and the subchondral bone layer.Conclusions: We showed that the labeling of rabbit MSCs with anti-mortalin antibody-conjugated i-QDs is a tolerable procedure and provides a stable fluorescence signal during the cartilage repair process for up to 26 weeks after transplantation.The results suggest that i-MSCs did not inhibit and indeed contributed to the regeneration of osteochondral defects.
其他文献
The monoclonal antibody D32.10, raised against serum-derived Hepatitis C virus (HCVsp), recognizes a highly conserved discontinuous antigenic determinant: E1 (aa297-306), E2(aa480-494 and E2(aa613-621
The monoclonal antibody D32.10, raised against serum-derived Hepatitis C virus (HCVsp), recognizes a highly conserved discontinuous antigenic determinant: El (aa297-306), E2(aa480-494 and E2(aa613-621
Botulinum neurotoxins (BoNTs) and ricin are some of the most potent humans toxins described.The most common route of intoxication is through ingestion of contaminated food or drink.In addition, these
Cancer immunotherapy, particularly antigen-specific cancer vaccines, has emerged as an attractive approach due to their ability to kill tumor cells without harming normal cells.The understanding ofonc
TLP is a tumor-associated antigen and a 100 kDa protein overexpressed in lung tumors and other epithelial adenocarcinomas.It is immunogenic in humans as shown by serum antibodies.Since TLP is a fragme
Members of the Camelidae family produce immunoglobulins devoid of light chains.We have characterized variable domain fragments of these heavy chain antibodies, the VHH, from llamas immunized with huma
The emerging use of non-immunoglobulin derived protein binders for therapeutic applications has motivated the development of various strategies for extending the in vivo half-life of such agents.Here
The smallest possible antigen binding domain has been built into a multimer molecule, dubbed as Combody, by fusing to a coiled-coil structure derived from cartilage oligomeric matrix protein.Combody h
Capillary electrophoresis (CE) technology has long been used for separation and analysis of pharmaceutical products.As the development of therapeutic monoclonal antibodies and other biologics increase
We are developing a monoclonal antibody that recognizes an oncofetal glycoepitope as a potential probe for identifying cancer stem cells.Mannitou antibody labels significantly more restrictively in se